Blog
RSS FeedPosted by Michael Wonder on 12 Jun 2019
New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study
10 June 2019 - At two years, advanced prostate cancer patients taking the trial drug, in addition to their standard treatment, ...
Posted by Michael Wonder on 16 Apr 2019
New genetic therapies in cancer treatment could impact benefits plans
12 April 2019 - In September 2018, Health Canada approved, for the first time, the use of a chimeric antigen ...
Posted by Michael Wonder on 23 Mar 2019
A patient’s journey with melanoma and drug coverage concerns
22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...
Posted by Michael Wonder on 21 Jan 2019
Will price be a barrier to new cancer immunotherapy?
19 January 2019 - Advisory group CADTH recommends no funding for new CAR-T therapy until drug company lowers cost. ...
Posted by Michael Wonder on 17 Jan 2019
Gene therapy drug Kymriah should be publicly covered if manufacturer drops price, report recommends
16 January 2019 - A groundbreaking gene therapy for cancer could cost the Canadian health care system more than $400 ...
Posted by Michael Wonder on 16 Dec 2018
2019 oncology drugs in pipeline — survey
14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...
Posted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Tagrisso
5 November 2018 - CADTH has published its initial recommendation on the use of osimertinib mesylate for the first-line treatment ...
Posted by Michael Wonder on 05 Nov 2018
CADTH publishes initial recommendation for Lenvima
5 November 2018 - CADTH has published its initial recommendation on the use of lenvatinib mesylate in combination with everolimus ...
Posted by Michael Wonder on 17 Aug 2018
Hundreds of cancer patients received partial doses of medication
16 August 2018 - Hundreds of cancer patients in Canada did not receive the full dose of three highly concentrated ...
Posted by Michael Wonder on 08 Jul 2018
CADTH publishes initial pERC recommendation for Roche's alectinib hydrochloride
6 July 2018 - The outcome relates to the use of alectinib hydrochloride (Alecensaro) for the first-line treatment of patients ...
Posted by Michael Wonder on 21 Jun 2018
Whistler woman forced to fundraise for cancer drugs
21 June 2018 - Joni Denroche staying positive after insurance fails to cover needed treatment. ...
Posted by Michael Wonder on 04 Jun 2018
Same cancer, worse results and twice the cost in the US
1 June 2018 - Americans paid twice as much as Canadians for health care, but they didn't get twice the ...
Posted by Michael Wonder on 21 May 2018
Give paediatric cancer sufferers the help they need
21 May 2018 - Her necklace has 650 beads, one for each medical procedure she has been through. ...
Posted by Michael Wonder on 17 May 2018
This 12-year-old leukaemia survivor is fighting for equal access to medicine for all Canadians
17 May 2018 - Helena Kirk, a 12-year-old leukaemia survivor, helped spearhead a proposal to the Minister of Health with support ...
Posted by Michael Wonder on 02 May 2018
Ontario NDP promise take-home cancer drug coverage ahead of election
30 April 2018 - NDP Leader Andrea Horwath is promising universal access to take-home cancer drugs if her party wins ...